Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Craig J. Landau"'
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose Abuse and misuse of prescription opioids are serious public health problems. Abuse-deterrent formulations are an intervention to balance risk mitigation with appropriate patient access. This study evaluated the effects of physicochemical barr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1798fb41d3c66eefdc097ebdb6d0a86f
https://doi.org/10.1002/pds.3522
https://doi.org/10.1002/pds.3522
Autor:
Simon H. Budman, Stephen F. Butler, Howard D. Chilcoat, Theresa A. Cassidy, Paul Coplan, Ryan A. Black, Craig J. Landau
Publikováno v:
The Journal of Pain. 14:351-358
Oxycodone hydrochloride controlled-release, also known as extended-release oxycodone (ER oxycodone), was reformulated with physicochemical barriers to crushing and dissolving intended to reduce abuse through nonoral routes of administration (ROAs) th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c75e357a1e46e59bd644f5918ebe2fa
https://doi.org/10.1016/j.jpain.2012.08.008
https://doi.org/10.1016/j.jpain.2012.08.008
Autor:
Gosford Sawyerr, Catherine Munera, Craig J. Landau, Warren Wen, Steve Sitar, Steven R. Ripa, Deborah J. Steiner
Publikováno v:
Journal of Pain and Symptom Management. 42:903-917
This article presents the results of a pivotal Phase 3 study that assesses a new treatment for the management of chronic low back pain: a transdermal patch containing the opioid buprenorphine. In this randomized, placebo-controlled study with an enri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8a73e012e3e8c09faf4deb23fff304
https://doi.org/10.1016/j.jpainsymman.2011.04.006
https://doi.org/10.1016/j.jpainsymman.2011.04.006
Autor:
William D. Carr, Steven R. Ripa, Nelson E. Sessler, Craig J. Landau, Catherine Munera, Albert J. Razzetti
Publikováno v:
Clinical Therapeutics. 29:2179-2193
Objective: This study compared the efficacy and safety profile of buprenorphine transdermal delivery system (BTDS) and placebo in subjects with persistent noncancer-related pain who required opioid analgesics. Methods: This was a multicenter, double-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3c6ca31bc18a7c6e5888382f7dc61f1
https://doi.org/10.1016/j.clinthera.2007.10.010
https://doi.org/10.1016/j.clinthera.2007.10.010
Autor:
Gilder L. Wideman, Michael Damask, Craig J. Landau, Marie Keffer, Mark Palangio, Ralph T. Doyle, John G. Jiang, Elena Morns, Anthony de Padova
Publikováno v:
Clinical Therapeutics. 22:600-612
The objective of this study was to compare the effectiveness of combination hydrocodone and ibuprofen with that of combination oxycodone and acetaminophen in the treatment of moderate to severe postoperative obstetric or gynecologic pain.Hydrocodone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cf6564ec092c274d2309a755f039ec0
https://doi.org/10.1016/s0149-2918(00)80047-8
https://doi.org/10.1016/s0149-2918(00)80047-8
Publikováno v:
Expert opinion on pharmacotherapy. 13(9)
The objective of this study was to evaluate continued pain control and tolerability of converting patients from Vicodin (hydrocodone/acetaminophen; HCD/APAP) to the buprenorphine transdermal system (BTDS).Adult patients with pain from osteoarthritis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0ee19d7c530d2404e814b5d05e6b853
https://pubmed.ncbi.nlm.nih.gov/22409388
https://pubmed.ncbi.nlm.nih.gov/22409388
Publikováno v:
The journal of pain. 12(11)
In this enriched design study, 1,160 opioid-experienced patients with chronic, moderate to severe low back pain entered an open-label run-in period; 660 demonstrated analgesic benefit from and tolerability to buprenorphine transdermal system 20 mcg/h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3032461d38405684a07730626fd79bee
https://pubmed.ncbi.nlm.nih.gov/21807566
https://pubmed.ncbi.nlm.nih.gov/21807566
Publikováno v:
Journal of opioid management. 6(3)
Background: This multicenter, parallel-group, 35-day study in adults with osteoarthritis (OA) pain evaluated the analgesic efficacy and safety of buprenorphine transdermal system (BTDS) designed for 7-day wear.Methods: Patients with OA pain inadequat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633e7809d957e4c67a0011ddc92beecb
https://pubmed.ncbi.nlm.nih.gov/20642248
https://pubmed.ncbi.nlm.nih.gov/20642248
Autor:
Mark Palangio, Michael Damask, Anthony de Padova, Gilder L. Wideman, John G. Jiang, Marie Keffer, Ralph T. Doyle, Elena Morris, Craig J. Landau
Publikováno v:
Clinical therapeutics. 22(8)
Objective The objective of this study was to demonstrate a dose-response effect with 1- and 2-tablet doses of combination hydrocodone 7.5 mg with ibuprofen 200 mg and placebo in patients with moderate to severe postoperative abdominal or gynecologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd60565b3514fafbc56a1f45e659f44
https://pubmed.ncbi.nlm.nih.gov/10972635
https://pubmed.ncbi.nlm.nih.gov/10972635
Autor:
Michael Damask, Mark Palangio, Elena Morris, Craig J. Landau, Anthony de Padova, John G. Jiang, Ralph T. Doyle
Publikováno v:
Clinical therapeutics. 22(7)
The objective of this study was to compare the effectiveness of combination hydrocodone 7.5 mg and ibuprofen 200 mg with that of combination codeine 30 mg and acetaminophen 300 mg for the treatment of chronic pain.Hydrocodone 7.5 mg with ibuprofen 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f915f3370dd5a562dfa9387464643f52
https://pubmed.ncbi.nlm.nih.gov/10945514
https://pubmed.ncbi.nlm.nih.gov/10945514